<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Proceedings/Doxazosin: a distinctive approach to risk reduction of coronary heart disease in hypertensive patients, symposium, Hamburg, West Germany, January 30, 1988</dc:title>
  <dc:creator>HAYDUK, K</dc:creator>
  <dc:contributor>Pfizer International (Funder/Sponsor)</dc:contributor>
  <dc:contributor>Doxazosin: a distinctive approach to risk reduction of coronary heart disease in hypertensive patients. Symposium (1988-01-30)</dc:contributor>
  <dc:relation>The American heart journal -- Am. heart j, CODEN AHJOA2, ISSN 0002-8703, Vol. 116 (6) , pp. 1707-1840</dc:relation>
  <dc:date>1988</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Proceedings</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>dissem</dc:format>
  <dc:subject xml:lang="fr">Appareil circulatoire pathologie</dc:subject>
  <dc:subject xml:lang="fr">Bloquant α-adrénergique</dc:subject>
  <dc:subject xml:lang="fr">Cardiopathie coronaire</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Congrès</dc:subject>
  <dc:subject xml:lang="fr">Doxazosine</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hypertension artérielle</dc:subject>
  <dc:subject xml:lang="fr">Récepteur α1-adrénergique</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Cardiovascular disease</dc:subject>
  <dc:subject xml:lang="en">Alpha blocking agent</dc:subject>
  <dc:subject xml:lang="en">Coronary heart disease</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Congress</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Hypertension</dc:subject>
  <dc:subject xml:lang="en">α1-Adrenergic receptor</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Aparato circulatorio patología</dc:subject>
  <dc:subject xml:lang="es">Bloqueador α-adrenérgico</dc:subject>
  <dc:subject xml:lang="es">Cardiopatía coronaria</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Congreso</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hipertensión arterial</dc:subject>
  <dc:subject xml:lang="es">Receptor α1-adrenérgico</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02F05: Antihypertenseurs / Antihypertensive agents</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 7061966</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>